The leukocyte integrin ␣ L ␤ 2 mediates cell adhesion and migration during inflammatory and immune responses. Ligand binding of ␣ L ␤ 2 is regulated by or induces conformational changes in the inserted (I) domain. By using a micropipette, we measured the conformational regulation of two-dimensional (2D) binding affinity and the kinetics of cell-bound intercellular adhesion molecule-1 interacting with ␣ L ␤ 2 or isolated I domain expressed on K562 cells. Locking the I domain into open and intermediate conformations with a disulfide bond increased the affinities by ϳ8000-and ϳ30-fold, respectively, from the locked closed conformation, which has similar affinity as the wild-type I domain. Most surprisingly, the 2D affinity increases were due mostly to the 2D on-rate increases, as the 2D off-rates only decreased by severalfold. The wild-type ␣ L ␤ 2 , but not its I domain in isolation, could be up-regulated by Mn 2؉ or Mg 2؉ to have high affinities and on-rates. Locking the I domain in any of the three conformations abolished the ability of divalent cations to regulate 2D affinity. These results indicate that a downward displacement of the I domain C-terminal helix, induced by conformational changes of other domains of the ␣ L ␤ 2 , is required for affinity and on-rate up-regulation.
Lymphocyte function-associated antigen-1, or ␣ L ␤ 2 integrin, mediates a variety of leukocyte adhesion and signaling processes, such as firm adhesion to the vascular surface during the initiation of inflammatory reaction or during lymphocyte trafficking, transendothelial migration into inflamed tissues or lymphoid tissues (1) , and adhesion to antigenpresenting cells to form the immunological synapse (2) . ␣ L ␤ 2 binds to members of the immunoglobin superfamily of cell adhesion molecules, including intercellular adhesion molecule-1 (ICAM-1). 3 Ligand binding of inactive ␣ L ␤ 2 is of too low an affinity to be detected by many conventional methods, but high affinity can be induced by cell activation, a process referred to as inside-out signaling. Conformational changes in the ␣ L ␤ 2 molecule, especially in the inserted (I) domain, are required for such affinity up-regulation. Ligand binding to the I domain can also induce conformational changes that propagate from the integrin head to its tail to enable binding of cytoplasmic molecules, a process referred to as outside-in signaling. Thus, conformational changes are crucial to the regulation of integrin functions (3) .
Although the crystal structures of several integrin domains have been solved, including the whole extracellular segment of the ␣ v ␤ 3 integrin alone (4) and in complex with an RGD peptide (5), the dynamic process for the conformational regulation of integrin binding affinity and kinetics remains elusive. The ligand-binding site of ␣ L ␤ 2 for ICAM-1 is located at the I domain in the ␣ L subunit, which is so named because its ϳ200 amino acids are inserted between blades 2 and 3 of the ␤-propeller domain (6) . The I domain is also named ␣A domain because it assumes a dinucleotide-binding fold with a central ␤-sheet surrounded by several ␣ helices that is similar to the A domains of von Willebrand factor (7) . The C and N termini on one face connect the I domain to the ␤-propeller domain. A metal ion-dependent adhesion site (MIDAS) is located on the opposite face, which, together with the surrounding residues, forms the ICAM-1-binding site. Crystallographic (8) , nuclear magnetic resonance (9, 10) , and molecular dynamics simulation (11) studies have provided evidence for conformational changes of the ␣ L I domain among three distinct conformations, named open, intermediate, and closed conformers. It has been proposed that three residues of the ␤6-␣7 loop interact with the ␣1 helix one at a time to hold the ␣7 helix in three distinct positions that correspond to these three conformations; each position moves the ␣7 helix downward by one helical turn (8) . The movement of the ␣7 helix is linked to a repacking of the hydrophobic face of this ␣ helix, which is coupled to the structural rearrangement of the MIDAS and divalent cation coordination (Fig. 1A) .
The regulation of ligand binding affinity and kinetics of ␣ L ␤ 2 by conformational changes has been examined by using mutants that introduce a pair of cysteines to form a disulfide bond to lock the ␣ L I domain in either the closed, intermediate, or open conformation by altering the ␣7 helix position (8, 12) . The isolated locked I domain mutants exhibited low (6. (8, 13) . The increase in on-rate (ϳ50 -60-fold) and the decrease in off-rate (ϳ100 -250-fold) both contributed to the increase in binding affinity from the locked closed to the locked open I domains. The isolated locked open I domain was sufficient for full adhesive activity, since it had a 3D binding affinity for ICAM-1 (and * This work was supported in part by National Institutes of Health Grants AI44902 and AI38282 (to C. Z.), AI049400 (to P. S.), and CA31798 (to T. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Recipient of a United Negro College Fund-Merck postdoctoral fellowship. Present address: Dept. of Chemical and Materials Engineering, Arizona State University, Tempe, AZ 85287. 2 To whom correspondence and reprint requests should be addressed: Wallace H.
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mediated ICAM-1-dependent cell adhesion) at a level similar to those of fully activated wild-type (WT) ␣ L ␤ 2 (12) (13) (14) . Ligand binding in the I domain can be regulated by and can induce a series of intra-and inter-domain conformational changes, which propagate through other domains from the cytoplasmic tail to the I domain (inside-out signaling) or from the I domain to the cytoplasmic tail (outside-in signaling). It has been proposed that, prior to the initiation of inside-out signaling, the inactive integrin assumes a bent conformation. Binding of an intracellular protein (e.g. talin) to the integrin cytoplasmic domain may result in the separation of the ␣-and ␤-cytoplasmic/transmembrane domains, thereby destabilizing the extracellular interface between the two subunits. This may lead to a switchblade-like opening of the bent integrin, resulting in an extended conformation. The disruption of the subunit interface may enable the hybrid domain to swing out from the I-like domain in the ␤ subunit, facilitating the downward movement of the I-like domain C-terminal ␣ helix that may be coupled to a rearrangement in the MIDAS of the I-like domain (Fig. 1B) (15) (16) (17) . An "intrinsic ligand," a residue in the I domain ␣7 helix, may bind the activated I-like domain MIDAS (18, 19) . This binding may pull down the ␣7 helix of the I domain and convert it to the activated conformation for high affinity ligand binding (20) .
Although various lines of evidence have been obtained in support of the above models for affinity/kinetic regulation by conformational changes, previous measurements were made by SPR with one of the binding partners in the fluid phase, i.e. 3D kinetics and affinity 4 (8, 13, 14) . By comparison, cell-cell adhesion and cell-substrate adhesion are mediated by binding between receptors and ligands anchored on two apposing surfaces, i.e. two-dimensional (2D) interactions. The binding affinity K a is the ratio of equilibrium concentration of bonds to those of free receptors and ligands. However, concentration is measured as number of molecules per volume in 3D but number of molecules per area (i.e. surface density) in 2D, resulting in different units for K a (m Ϫ1 in 3D and m 2 in 2D not be readily converted from their 3D counterparts (21) . It is therefore important to directly measure in situ the more physiologically relevant 2D binding affinity and kinetic rates.
Here we quantified the regulation of 2D binding affinity and kinetics of the ␣ L ␤ 2 -ICAM-1 interaction by conformational changes using the micropipette adhesion frequency experiment (22) . Our results showed that when expressed on the cell surface, isolated locked I domains exhibited binding affinities and kinetics similar to those of whole ␣ L ␤ 2 integrins containing I domains locked in the corresponding conformations. Up-regulation of ligand binding affinity of the ␣ L ␤ 2 was mostly because of the conformational changes in the I domain, which in turn was regulated by other domains by pulling down the I domain C-terminal ␣7 helix. Our data also revealed a surprising discrepancy between the 2D and 3D off-rate measurements. The 2D off-rates of the locked open and locked closed I domains only differed a few fold, which is in sharp contrast to the 3D results of ϳ100-fold difference.
EXPERIMENTAL PROCEDURES
Cell Lines, Proteins, and Antibodies-The human erythroleukemia cell line K562 stably transfected with WT, locked open (K287C/K294C), locked intermediate (L161C/F299C), or locked closed (L289C/K294C) ␣ L I domain fused with a platelet-derived growth factor receptor transmembrane domain and the first five amino acids of its cytoplasmic domain or with intact ␣ L ␤ 2 containing the WT or locked I domains have been described previously (8, 13) .
Human red blood cells (RBCs) were isolated from whole peripheral blood of healthy donors. Approximately 7 ml of whole blood was collected by venipuncture into sterile Vacutainers (BD Biosciences) containing EDTA. This was carefully layered over 3 ml of Histopaque 1119 (Sigma) and centrifuged (30 min, 2000 ϫ g, room temperature). The supernatant was removed, and the pelleted RBCs were washed once in RBC storage solution (EAS45) (23) . RBCs were stored aseptically at 4°C in EAS45 at 20% hematocrit. Mouse and human glycosylphosphatidylinositol (GPI)-anchored ICAM-1 molecules were purified from Chinese hamster ovary cell transfectants by affinity chromatography 5 (24) . Fluorescein isothiocyanate (FITC)-conjugated mouse anti-human ␣ L I domain monoclonal antibody (mAb) MEM-25 (IgG 1 ) (Caltag Laboratories, Burlingame, CA) and a nonbinding FITC-conjugated mouse isotype-matched control antibody were used to determine surface expression of the I domain and ␣ L ␤ 2 on K562 cells by immunofluorescence flow cytometry. FITC-conjugated mouse mAb MEM-111 (Caltag Laboratories) and FITC-conjugated rat mAb YN1/1.7.4 (eBioscience, San Diego) were used to determine the site densities of the reconstituted human and mouse ICAM-1, respectively. The mouse anti-human ␣ L mAb 38 (Ancell, Bayport, MN) was used for antibody-antigen adhesion kinetic measurement. FITC-conjugated rat anti-mouse IgG 2a mAb (Fcspecific) (Pharmingen) was used to measure the site density of mAb 38 coated on RBCs. The anti-ICAM-1-capturing mouse mAb CA7 was a generous gift of Dr. Robert Rothlein (Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT). The integrin-activating mAb CBR LFA1/2 has been described previously (25) .
Coupling of ICAM-1 to RBCs-Mouse or human GPI-ICAM-1 was reconstituted in RBC membrane by a 2.5-h incubation with different concentrations to achieve the desired site densities (26) . Capture antibody CA7 or anti-human ␣ L I domain mAb 38 was covalently coupled to the membranes of RBCs by the chromium chloride (CrCl 3 ) method described previously (22 (MESF) . A calibration curve was generated by plotting the MESF against the mean fluorescence intensities of each of the five bead populations. The MESF for the cells were calculated by comparing the fluorescence intensities of the cells with those of the standard beads. The site densities on the cell surface of the molecule in question were determined by dividing the MESF value by the apparent cell surface area and the fluorophore/protein ratio.
Micropipette Adhesion Frequency Assay-The micropipette adhesion frequency assay has been described previously (22) . K562 cells were washed with Hanks' balanced salt solution without calcium and without magnesium (HBSSϪ) three times before the experiments and resuspended in HBSSϪ with or without 2 mM Mn 2ϩ or 2 mM Mg 2ϩ plus 2 mM of EGTA in the presence or absence of 10 mM dithiothreitol (DTT) and 45-55% double distilled H 2 O to partially swell the RBCs. In some control experiments, K562 cells were washed with HBSSϪ with 5 mM EDTA and then with HBSSϪ before being assayed in HBSSϪ with or without 5 mM EDTA. In other control experiments, the HBSSϪ/EDTAwashed cells were incubated with 2 mM of Mn 2ϩ , Mg 2ϩ (plus 2 mM EGTA), or Ca 2ϩ and then washed with HBSSϪ before being assayed in HBSSϪ. By using two micropipettes, a K562 cell and an RBC were aspirated gently and aligned with a small axial gap between them (Fig. 2) . One pipette was connected to a computer-controlled piezoelectric actuator that was programmed to move back and forth at a uniform rate of 1 m/s. Cells were placed in contact for a prescribed duration and then retracted away from each other. Upon retraction, the unaspirated portion of the RBC was either separated freely from the K562 cell and 5 P. Selvaraj, unpublished data. returned to its original spherical shape, indicating no adhesion (scoring 0), or remained bound with an elongated shape, indicating adhesion (scoring 1), until final detachment by further retraction. This test cycle was repeated 100 times using the same pair of cells, keeping the contact duration (t) and the area (A c , ϳ3 m 2 ) constant, and averaging the adhesive scores to calculate an adhesion frequency (P a ). More than 5 pairs of cells were tested per contact time to obtain the mean Ϯ S.E. of P a at that t. The contact duration was varied from 0.5 to 60 s to obtain a P a versus t binding curve. For each species of I domain or ␣ L ␤ 2 , 2-3 curves were generated using a total of ϳ100 pairs of cells by varying the site densities of I domain/␣ L ␤ 2 (m r ) or ICAM-1 (m l ). The 2D effective binding affinity (A c K a ) and off-rate (k off ) were calculated by fitting Equation
to the binding curves by using iteratively reweighted nonlinear regression (27) . For some experiments, the adhesion frequency was determined at sufficiently long contact duration without measuring a full binding curve to simply estimate the effective binding affinity (
which is derived from the steady-state version (i.e. t 3 ∞) of Equation 1.
RESULTS
Measuring Specific Integrin-ICAM-1 Binding Affinity and KineticsExpressed on the cell surface, both isolated I domains and whole ␣ L ␤ 2 heterodimers mediated sufficient levels of adhesion with ICAM-1 reconstituted on RBC to be measured by the micropipette, which is capable of measuring interactions with affinities too low for many conventional adhesion assays to detect (28) . By sorting the K562 cells to express appropriate levels of I domain or whole ␣ L ␤ 2 and reconstituting appropriate levels of ICAM-1 on RBCs, the equilibrium frequencies of adhesion of each pair of interacting molecules were adjusted to midrange levels, i.e. 0.2-0.8. To estimate reliably binding parameters, 2-3 curves were generated for each species by varying the site densities of integrin or ICAM-1 or both (Fig. 3) . The detected interactions were mostly specific, as the adhesion frequency between the K562 cells and RBCs without ICAM-1 coupling was Ͻ0.06, which was deemed as nonspecific binding ( Fig. 3 and data not shown). The use of Equations 1 and 2 requires that P a be a specific adhesion frequency, which can be calculated from the total adhesion frequency (P t ) after removing the nonspecific adhesion frequency (P n ) according to Equation 3 (21, 26) .
For all integrin molecules tested, measurement of specific ICAM-1 binding affinity and kinetics requires that the I domain MIDAS be occupied by a divalent cation, as binding was reduced to the nonspecific level when measured in HBSSϪ with EDTA (Fig. 4A) . Washing the cells first with HBSSϪ containing EDTA and then with HBSSϪ to remove EDTA and resuspending them in HBSSϪ for adhesion test also diminished binding to the nonspecific level (Fig. 4B) . Thus, after stripping the metal ion off the I domain MIDAS with EDTA, no specific adhesion frequency above the noise level could be calculated from Equation 3, thereby preventing estimates of integrin-ICAM-1 binding affinity and kinetics from Equations 1 and 2. However, washing the cells previously exposed to divalent cations with and then performing micropipette assay in HBSSϪ without EDTA resulted in sufficiently high specific adhesion signals above noise from Equation 3 . This indicates that without using EDTA, the metal ion pre-bound to the I domain MIDAS remained bound for hours in HBSSϪ to enable specific integrin-ICAM-1 binding.
To study further the regulation of ICAM-1 binding affinities of the different I domains and whole ␣ L ␤ 2 by divalent cations, we chose the base-line experimental condition to be one in which K562 cells were first allowed to bind divalent cations, washed with HBSSϪ, and then assayed for ICAM-1 binding in HBSSϪ. Inclusion of 2 mM Mn 2ϩ or 2 mM Mg 2ϩ in the chamber solution where micropipette adhesion assay was performed was chosen to be the activating experimental condition. Note that in both the base-line and activating conditions, it was the specific adhesion mediated by binding of ICAM-1 to the I domain MIDAS pre-bound with a divalent cation that was measured. Specific ICAM-1 binding affinities and kinetics of WT and mutant ␣ L I domain as well as WT and mutant whole ␣ L ␤ 2 in these two conditions were compared in the present study to elucidate their conformational regulation. The EDTA condition was not used because it did not allow specific ICAM-1 binding affinity and kinetics to be measured by our method.
The Locked Open, Intermediate, and Closed I Domains Bind ICAM-1 with High, Intermediate, and Low Affinities-Tested under the base-line condition, locking the I domain into high and intermediate conformations increased the binding affinities by ϳ8,000-and ϳ30-fold compared with the locked closed I domain, which was on the same order of magnitude as the affinity of the WT I domain (p Ͼ 0.06) (Fig. 5A and TABLE ONE). Therefore, the alternation of the C-terminal ␣7 helix position was sufficient to regulate the ligand binding affinity of the I domain when expressed on cell surface, in agreement with the 3D SPR measurement (8, 13) and consistent with the cell binding measurement (29) . Most surprisingly, differences among the off-rates for the four isolated I domains were modest at best, with the locked open I domain having the smallest off-rate of 0. 41 ϳ2-fold (Fig. 7A) (Fig. 7 ), indicating that DTT had no adverse effects on the I domain-ICAM-1 interaction. In the base-line condition, DTT treatment reduced the ICAM-1 binding affinity of the open I domain 3-4 orders of magnitude to the level of that of the WT I domain but had little effect on the affinity of the closed I domain, which was already similar to that of the WT I domain (Fig. 7) , indicating that these I domains returned to (or remained at) the inactive conformation after unlocking the disulfide bonds. In addition, unlocking the disulfide bonds with DTT treatment resumed the ability of Mn 2ϩ and Mg 2ϩ to up-regulate 2D ICAM-1 binding affinity of the I domain mutants to levels comparable with those of the WT I domain (Fig. 7C) . Thus, the effects on I domain-ICAM-1 binding affinity of replacing the residues in the ␣7 helix and ␤1-strand by a pair of cysteines are due solely to the fixation of the ␣7 helix position by a disulfide bond. Taken together, our data indicate that a 3-4-order of magnitude of changes in the ICAM-1 binding affinity of the I domain can be regulated solely by the movement of its ␣7 helix. (Fig. 8A) . Thus, when the I domain pre-bound with a divalent cation was locked at the closed, intermediate, or open position, the 2D binding affinities for ICAM-1 were clamped at low, intermediate, or high levels with no range (for isolated I domains; Fig. 7A ) or a narrow range (for I domains contained in the whole ␣ L ␤ 2 ; Fig. 8A ) of regulation by Mn 2ϩ or Mg 2ϩ . These data are consistent with the cell binding measurement (29) . The 2-5-fold of affinity up-regulation by Mn 2ϩ and Mg 2ϩ likely resulted from conformational changes of other integrin domains. Mn 2ϩ and Mg 2ϩ have been shown to induce the switchblade-like conformational change of the whole integrin and stabilize the integrin in an extended conformation, which moves the I domain ϳ10 nm upward further above the cell membrane (30) . Lengthening cell surface receptors has been shown to increase 2D binding affinity by enhancing its accessibility to ligands on the apposing cell surface (31) . In sharp contrast to the isolated WT I domain and to the mutant ␣ L ␤ 2 containing locked I domains, the 2D binding affinities of WT ␣ L ␤ 2 for ICAM-1 measured in Mn 2ϩ or Mg 2ϩ were increased ϳ1500-and ϳ380-fold, respectively, compared with the value measured in HBSSϪ (Fig. 8A) .
Movements of the I Domain
To exclude the possibility that the mutations in the I domain might have effects on ␣ L ␤ 2 -ICAM-1 binding affinity other than preventing the I domain ␣7 helix movement, we again used DTT to unlock the disulfide bonds. In the base-line condition, DTT treatment again reduced the 2D ICAM-1 binding affinity of the mutant ␣ L ␤ 2 containing an open I domain 3-4 orders of magnitude to the level of that of the WT ␣ L ␤ 2 but had little effect on the affinity of the mutant ␣ L ␤ 2 containing a closed I domain, which was already similar to that of the WT ␣ L ␤ 2 (Fig. 8) , indicating that these I domains returned to (or remained at) the inactive conformation after unlocking the disulfide bonds. In addition, DTT again resumed the full 3-4 log range of affinity regulation of the mutant 8B). Because WT and mutant ␣ L ␤ 2 with and without DTT treatment were able to bind ICAM-1 specifically in HBSSϪ but not in EDTA, the MIDAS of the I domain in the context of the whole integrin must be occupied by a divalent cation in HBSSϪ, just as it is in isolation. Affinity up-regulation by several orders of magnitude requires the downward movements of the I domain ␣7 helix, because the isolated WT I domain and isolated mutant I domains unlocked with DTT were unable to be up-regulated by Mn 2ϩ or Mg 2ϩ to a high affinity state (see above). Thus, our data suggest a coupling between the I domain conformation and the global conformation of the whole integrin, such that changes in the latter results in changes in the former, leading to changes in the ␣7 helix position. In addition, to induce the global conformational changes, Mn 2ϩ or Mg 2ϩ must bind to metal ion-binding sites on ␣ L ␤ 2 other than the I domain MIDAS under the activating condition, because the I domain MIDAS had already been occupied by a divalent cation. Unlike the I domain MIDAS, these other metal ion-binding sites could not hold on to the divalent cations bound to them when the cells were washed in HBSSϪ. In other words, divalent cations must dissociate from the metal-binding sites on the whole integrin responsible for inducing the switchblade-like conformational change much more rapidly than from the I domain MIDAS.
The Micropipette Assay Is Capable of Measuring Slow Off-rate-The 2D off-rates of the various ␣ L ␤ 2 integrin constructs dissociating from ICAM-1 observed in this study fell in a narrow range from 0.2 to 2.5 s Ϫ1 .
By comparison, the 3D off-rates of the corresponding I domain species measured by SPR spanned a much wider range, extending the high end by severalfold and the low end by an order of magnitude ( (32) . The kinetic parameters shown in Figs. 5 and 6 (summarized in TABLE ONE) were measured using mouse ICAM-1 because of its much higher availability. By comparison, the previous SPR studies used human ICAM-1 (8, 13, 14) . We therefore tested whether ICAM-1 from different species dissociated at much different off-rates by measuring the 2D kinetics of human ␣ L ␤ 2 containing the locked open I domain interacting with human ICAM-1. The binding parameters of ␣ L ␤ 2 for mouse and human ICAM-1 were very similar, especially the 2D A c K a (Fig. 10) . Although the 2D off-rates differed slightly (Ͻ2-fold), they were of the same order of 0.1 s Ϫ1 (TABLE TWO) , which is still an order of magnitude faster than the 3D off-rate measured in the previous SPR study (8, 13, 14) . Thus, the differences in the 2D and 3D off-rates were not caused by the different ICAM-1 species used.
ICAM-1 Coupled to RBC via GPI Anchor and via a Capture mAb Have Similar
Off-rates-Both the mouse and human ICAM-1 used to measure the kinetic rates shown in Figs. 4 -10 were fusion proteins whose transmembrane and cytoplasmic domains were replaced by a GPI anchor for its easy reconstitution into the RBC membrane. To assess the effects of ICAM-1 presentation on the 2D off-rate, we performed kinetic measurement of isolated locked open I domain for ICAM-1 captured by a nonblocking anti-ICAM-1 mAb pre-coated on the RBC surface by using chromium chloride coupling (22) . GPI-anchored human ICAM-1 was captured using mAb CA7, which binds to the D5 domain of human ICAM-1. Because of the high affinity of antibody-antigen interaction, only submicrogram/ml concentration was required to capture enough ICAM-1 on the RBC surface. By comparison, submilligram/ml concentration was required for a sufficient number of ICAM-1 to insert their GPI anchors into the RBC membrane. This 1000-fold difference in the required concentrations ensured that pre-coating CA7 was required for RBC to acquire from low concentration incubation a high enough ICAM-1 site density for specific ␣ L ␤ 2 adhesion. Indeed, a control experiment using RBC not pre-coated with CA7 and incubated with submicrogram/ml concentration of ICAM-1 resulted in no more than a background level of adhesion (data not shown). By comparison, incubating RBC pre-coated with CA7 with the same concentration of GPI-ICAM-1 enabled the measurement of a binding curve shown in Fig. 11 , which is comparable with that obtained using RBC without CA7 pre-coating but incubated with submilligram/ml concentration of GPI-ICAM-1. Thus, K562 ␣ L ␤ 2 had similar 2D affinities and off-rates for ICAM-1 regardless of the method by which it was coated on RBC ( Fig. 11 and TABLE TWO) , which is con-6 F. Zhang, P. Selvaraj, T. Springer, and C. Zhu, unpublished data. sistent with the knowledge that the binding site for ␣ L ␤ 2 resides on the D1 domain of ICAM-1, which is Ͼ20 nm distal to the membrane anchor (33) , and that the first two Ig domains (D1-D2) of ICAM-1 are sufficient for I domain binding (8) .
DISCUSSION
By using the micropipette adhesion frequency assay, we have obtained additional evidence for the model for affinity regulation by conformational changes in integrins (20) . Our data confirmed that an isolated ␣ L I domain is capable of supporting ICAM-1 binding with the affinity and kinetics regulated by the position of the C-terminal ␣7 helix. When expressed on the cell surface without other domains of ␣ L ␤ 2 , the isolated WT I domain has a 2D ICAM-1 binding affinity similar to that of the locked closed I domain, suggesting that the closed conformation is the default conformation of the I domain. The 2D binding affinity of the I domain for ICAM-1 was increased by ϳ8,000-and ϳ30-fold by locking the ␣7 helix into the respective open and intermediate conformations. Unlocking the ␣7 helix position with DTT treatment returned the 2D ICAM-1 binding affinity of the I domain mutant, regardless of into which conformation it is locked, to the level of the WT I domain. In addition, with the I domain MIDAS pre-occupied by a divalent cation, changing the Mn 2ϩ and Mg 2ϩ concentrations in the chamber solution could not regulate the force-free 2D affinities of the I domain mutant, regardless of into which conformation it is locked, and could only regulate the ICAM-1 binding affinities of the WT or unlocked mutant I domains within a narrow range (Ͻ2-fold). Thus, the downward movement of the ␣7 helix is necessary and sufficient for regulating the ligand binding affinity of the I domain, provided that the I domain MIDAS is bound with a divalent cation.
The binding affinities and kinetics of whole ␣ L ␤ 2 integrins containing locked I domains were measured for the first time in this study, although these mutants were studied previously for their ability to mediate cell adhesion (12) . The mutant ␣ L ␤ 2 containing a locked I domain, regardless of into which conformation it was locked, had the same orders of magnitude of binding affinity and off-rate as the corresponding values of the isolated I domain, indicating that the I domain has nearly the same ligand binding capacity as the intact ␣ L ␤ 2 heterodimer. When measured in the base-line condition, the WT ␣ L ␤ 2 bound ICAM-1 with a low affinity comparable with the ␣ L ␤ 2 mutant containing a locked closed I domain, similar to WT I domain in isolation. This suggests that, just as WT I domain in isolation, the low affinity conformation is the default conformation for the inactive WT ␣ L ␤ 2 . Mn 2ϩ and Mg 2ϩ were able to increase the 2D ICAM-1 binding affinity of WT ␣ L ␤ 2 to a level comparable with that of the mutant ␣ L ␤ 2 containing a locked open I domain. The ability of Mn 2ϩ and Mg 2ϩ to substantially up-regulate the ICAM-1 binding affinity of ␣ L ␤ 2 from the base-line condition was diminished when the position of the I domain ␣7 helix was locked, regardless of into which position it was locked. In the base-line condition, unlocking the ␣7 helix position by DTT returned the ICAM-1 binding affinities of the ␣ L ␤ 2 mutants to the level of inactive WT ␣ L ␤ 2 . In addition, DTT treatment resumed the full range of affinity regulation of these locked ␣ L ␤ 2 heterodimers by Mn 2ϩ and Mg 2ϩ . Therefore, just as in isolation, the position of the ␣7 helix regulates most of the ligand binding affinity when the I domain is in the context of the whole ␣ L ␤ 2 heterodimer. Unlike in isolation, the presence of the whole ␣ L ␤ 2 context enables the position of the I domain ␣7 helix to be regulated, provided that it is not locked in fixed conformations. The conformations of other ␣ L ␤ 2 domains have only limited capacities to regulate the ligand binding DECEMBER 23, 2005 • VOLUME 280 • NUMBER 51 affinity and kinetics once the I domain is locked, most likely through regulating the distance of the I domain ligand-binding site above the cell membrane. In other words, the regulation of ligand binding affinity and kinetics by other domains of WT ␣ L ␤ 2 is achieved mostly through their effects on the I domain. More specifically, the conformational changes in other domains have to propagate through the ␣7 helix (most likely resulting in an applied force that pulls the ␣7 helix downward) in order to regulate ligand binding affinity and kinetics. Mn 2ϩ and Mg 2ϩ must regulate the I domain conformation indirectly through the conformational changes in other domains of ␣ L ␤ 2 rather than directly binding to the I domain MIDAS. Actually, the I domain MIDAS held on to a divalent cation pre-bound to it for hours even in HBSSϪ. Thus would the WT ␣ L ␤ 2 and the unlocked ␣ L ␤ 2 mutants assume the low affinity conformation in the base-line condition and be up-regulated to the high affinity conformation in the activating condition. Few 2D affinity and on-rate for integrin-ligand interactions have been published previously. Because cell adhesion is governed by these 2D binding parameters rather than the 3D parameters, the measurements reported here contribute to fulfilling the unmet need. The measured 2D binding affinity and kinetic rate constants also provide an opportunity to compare these values with their 3D counterparts measured by SPR for the same molecular interactions (13) Although the 2D and 3D off-rates agree well in one case (locked intermediate I domain), significant discrepancies between the micropipette and SPR measurements are seen in all other cases (Fig. 12B) . Both cases exist for 2D k off Ͼ Ͼ 3D k off (locked open I domain and ␣ L ␤ 2 integrin) and 2D k off Ͻ Ͻ 3D k off (WT and locked closed I domain). It appears that the hundreds of fold of 3D off-rate differences among the different molecular species are greatly compressed into a much narrower 10-fold range of 2D off-rate differences (TABLE ONE) . This results in a significant expansion of 2D on-rate differences among the different I domain conformers into a much broader range than that of 3D on-rate differences among the same set of I domain conformers, as the range of affinity differences are similar in 2D and 3D.
2D Affinity Regulation of ␣ L ␤ 2 by Conformation Changes
It has been well known that removal of divalent cations prevents or rapidly detaches integrin-mediated cell adhesion (34) . It has also been observed that isolated WT I domain expressing K562 cells roll on ICAM-1 under flow, but locking the I domain into the open high affinity state results in firm adhesion to ICAM-1 (29) . Cell detachment results from diminishing integrin-ligand bonds, which are caused by decreases in affinity, which can be due to either a decrease in on-rate, an increase in off-rate, or a combination thereof. Similarly, stable, continuous rolling requires the balance of bond formation and dissociation to maintain the same number of bonds. Either an increase in on-rate or a decrease in off-rate could result in more bond formation than dissociation, thereby reducing the rolling velocity and transiting rolling to firm adhesion. Our data reveal that it is the tremendous regulation range of the 2D on-rate rather than the small regulation region of the 2D off-rate of the ␣ L ␤ 2 -ICAM-1 interaction that underlies the above regulation of adhesion functions.
The discrepancies between the 2D and 3D off-rates are surprising because it has been proposed that the discrepant conversions between FIGURE 12 . Correlation between 2D and 3D binding parameters. A, 2D effective binding affinities for the indicated K562 integrin constructs for mouse GPI-ICAM-1 measured in this work are plotted against the 3D binding affinities of the same but purified integrin constructs for human soluble ICAM-1 measured in three previous studies (cf. the 2D affinity and 3D affinity were because of on-rates, which have different units in 2D (per unit surface density per unit time) and 3D (per unit volumetric concentration per unit time) (21, 26, 31) . By comparison, off-rates were believed to have the same values regardless of whether they were measured in 2D or 3D because they have the same unit (per unit time) in either case (25, 31, (35) (36) (37) (38) . In the present study, however, the off-rates are found drastically different in 2D and 3D, yet the fold increases in binding affinity from the locked closed I domain to the locked open I domain are similar in 2D and 3D.
To examine the possible sources for the discrepancies between the 2D and 3D off-rates, several experiments were performed to rule out potential contributing mechanisms. The ability of the adhesion frequency assay to measure off-rate accurately has been questioned because all published 2D off-rates measured by this method fall in a narrow range (orders between 0.1 and 1 s Ϫ1 ) despite the fact that these off-rates govern dissociation of very different interactions (22, 26 -28, 31, 38 -41) . Micropipette adhesion frequency assay was performed to measure the slow kinetics of an ␣ L ␤ 2 mutant interacting with a blocking antibody ( Fig. 9 ) and of WT ␣ L ␤ 2 interacting with ICAM-1 in the presence of activating mAbs. 6 The results confirmed that the micropipette assay is capable of measuring 2D off-rates as slow as the 3D off-rates measured by SPR.
The adhesion frequency assay measures the likelihood of adhesion. For the assay to work well, the cell surface densities of the receptors and ligands have to be adjusted so that the repeated adhesion tests result in a mid-range of probabilities (ϳ0.2-0.8). This limits the dynamic range of the assay as follows: for a 0.2-0.8 probability the range can be spanned by only an ϳ10-fold difference in affinities between two interactions with the same site densities. To measure the 3-4 orders of magnitude of differences in the ICAM-1 binding affinities of the open and closed ␣ L I domains, K562 cells were sorted to obtain high expression of locked closed I domain (ϳ2000 m Ϫ2 ) and low expression of locked open I domain (ϳ10 m Ϫ2 ). Any errors in the site density determination would propagate as errors in the affinity estimates; however, the off-rate estimates should not be affected. Another potential problem may be transport limitations, which can cause problems in SPR measurements (42) . High affinity and fast onrate interactions may deplete free receptors and ligands before transport brings in a replacement, thereby lowering their local densities. The dissociated receptors/ligands may also rebind upon dissociation, thereby prolonging the apparent lifetime (reciprocal off-rate). However, the former effect would have only impacted the on-rate. The latter effect would have underestimated the off-rate of the locked open I domain, thereby overestimating the "true" differences in the off-rates between the locked-open and locked-closed conformers.
The use of ICAM-1 from different species might be another potential cause for the discrepancies. However, direct comparison between mouse and human ICAM-1 in a back-to-back experiment showed that human ␣ L I domain and ␣ L ␤ 2 bind to ICAM-1 from the two species not only with the same specificity and the same divalent cation dependence but also with very similar binding affinity and kinetics (TABLE TWO) . Therefore, the use of mouse ICAM-1 did not cause the observed discrepancies between the 2D and 3D off-rates. Mouse ICAM-1 is a reasonable ligand for characterizing human ␣ L ␤ 2 binding and its regulation by conformational change.
It has been shown that ligand binding kinetics of GPI-anchored receptor could be different from its transmembrane anchor counterpart (39) . ICAM-1 is known to exist as a dimer or multimer on the cell surface (43, 44) . However, the GPI-ICAM-1 used in the present study likely expresses as a monomer on the cell surface (43). Jun et al. (45) demonstrated that a single ICAM-1 monomer contains a complete binding site for ␣ L ␤ 2 . Therefore, the GPI-anchored ICAM-1 is able to bind ␣ L ␤ 2 with full competency. The monomeric nature of the present 2D GPI-ICAM-1 binding should not cause off-rate discrepancies, as the 3D interactions between the purified molecules in the previous SPR studies were also monomeric. It is also possible that GPI-anchored ICAM-1 could be extracted from the RBC membrane, thereby reducing the number of ICAM-1 molecules in the contact area available for ␣ L ␤ 2 binding. But this would have only impacted on-rates but would not have influenced the 2D off-rates (22, 26, 31, 39) . In addition, the GPI-anchor receptor may display a different lateral mobility on the cell membrane, which could affect its ligand binding kinetics. To assess this potential effect, we tested whether the GPI anchor of ICAM-1 had affected the binding parameters. We coupled ICAM-1 to RBCs by using a capturing mAb CA7. The binding between capture antibody and ICAM-1 is likely strong and long lasting; therefore, the m l will not decrease in this case. Micropipette measurements using GPI-anchored or antibody-captured ICAM-1 resulted in comparable binding affinities and off-rates, indicating that the use of GPI-ICAM-1 did not affect the binding parameters (TABLE TWO) .
The present results are also comparable with recently published 2D off-rates of ␤ 2 integrin dissociating from ICAM-1 (41, 46, 47) . Lomakina and Waugh (41) reported a 0.7 s Ϫ1 2D off-rate of neutrophil integrin interacting with ICAM-1 in the presence of Mg 2ϩ by using the micropipette adhesion frequency assay, which is comparable with our values but different from the 3D values. By using a flow chamber, Vitte et al. (46) measured bond lifetimes of Jurkat cell integrins interacting with ICAM-1 in the absence and presence of Mg 2ϩ or Mn 2ϩ . The dissociation curves exhibited at least two phases and hence cannot be interpreted using first-order kinetics. Nevertheless, the apparent off-rates (0.30 -0.44 s Ϫ1 ) of the initial phase (0 -2 s) are comparable with our 2D
values but not to the 3D values (TABLE ONE) (8, 12, 13) . Most interestingly, the apparent off-rates (0.032-0.094 s Ϫ1 ) of the later phase (2-10 s), which involves bond strengthening, are comparable with the 3D off-rates of the locked open I domain and of the Mn 2ϩ -up-regulated WT ␣ L ␤ 2 dissociating from ICAM-1. Apparent off-rates of the initial (and later) phase exhibited Ͻ4-fold (and Ͻ10-fold) of divalent cation regulation, which is consistent with our results but not with the 3D results. By using atomic force microscopy, Zhang et al. (47) measured rupture forces over a range of loading rates, which were analyzed by the dynamic force spectroscopy method to estimate 2D off-rates based on the Bell equation that assumes off-rate to increase exponentially with force. The zero-force extrapolations of 2D off-rates of 0.17 and 4 s Ϫ1 for high and low affinity ␣ L ␤ 2 estimated from the low loading rates (20 -10,000 pN/s) data are consistent with our values but are faster than the 3D off-rates of the high affinity I domain and activated ␣ L ␤ 2 . Corresponding values estimated from the high loading rates (10,000 -50,000 pN/s) data are even faster (40 and 57 s Ϫ1 ). Taken together, the differing 2D off-rates from their 3D counterparts are unlikely experimental artifacts as the 2D data were determined using three independent techniques by three different laboratories. Discrepancies between 3D and 2D off-rate have been reported for other molecular systems as well. The off-rates of platelet glycoprotein Ib␣ dissociating from the von Willebrand factor A1 domain were 0.0038 s Ϫ1 measured in 3D by radioimmunoassay (48) force-free mean lifetime of 30 s for extracting single diC14 lipids from the surface of a lipid:cholesterol vesicle, which is 50-fold shorter than the 3D counterpart estimated from solution measurement (54) . There are many differences between the 2D and 3D measurements, which could affect estimation of the kinetic parameters. Evans (55) suggested that molecular attractions exterior to a binding site could significantly prolong association in solution yet escape detection in force probe tests because the peripheral interaction might be overwhelmed by small forces (e.g. Ͻ1 pN). Likewise, application of force could eliminate pathways available to spontaneous dissociation, which would yield a slower apparent off-rate. It was therefore concluded that there should be no reason to expect the apparent lifetime derived from extrapolation of rupture kinetics to zero force to match the lifetime measured for dissociation in solution (55) . In addition, unlike 3D experiments, where the receptors and ligands approach each other and separate by free diffusion, in the micropipette measurement, the molecules are brought together and apart by the movement of the cell membranes. Cell membranes, especially the flexible RBC membrane, undulate under thermal excitations throughout the experiment. The standard deviation of RBC membrane fluctuation is of the order of tens of nanometers, 7 which may exert a small force on the molecular bond, especially when there is only one bond linking RBC to the K562 cell, which is likely the case. Membrane undulations could also influence 2D binding in other ways, e.g. making the contact time discontinuous. Anchoring the molecule to the cell membrane places restriction not only on translational but also on rotational diffusion of the molecule, which may also impact 2D binding. Whether, and if so how, these mechanisms contribute to the discrepancies between the 2D and 3D off-rates observed in this work is not known at this point. However, our data prompt renewed interest in theoretical modeling and experiment investigation of the influences of these factors on the 2D binding parameters.
